Froome tests for double of allowed limits of Salbutamol during 2017 Vuelta

The cycling world woke up to a bombshell yesterday: cycling superstar Chris Froome could be facing a racing ban after urine tests revealed elevated levels of Salbutamol during the 2017 Vuelta a España.Details were confirmed by Team Sky and later the UCI ahead of reports from The Guardian and Le Monde.There are a lot of layers to the story, so here are the facts: a urine sample from a test taken after stage 18 of the Vuelta — which Froome later won to become the first rider to win the Tour de France and Vuelta in succession since the race was moved to late summer in 1995 — revealed 2,000 nanograms per milliliter (ng/ml) of Salbutamol.That’s double the level allowed under WADA anti-doping rules. Salbutamol is a bronchial treatment for asthma that does not require a TUE (therapeutic use exemption) but is limited to 1,000 ng/ml. None of the other controls Froome underwent during the Vuelta revealed abnormal levels.Under existing procedural rules, the high number triggers a review, requiring Froome and Team Sky to explain to anti-doping authorities what caused the elevated concentration of Salbutamol. Right now, Froome is not facing a provisional ban.If Team Sky is unable to make its case, Froome could be facing a racing ban. How much is hard to say, but it could be as little as six months. It would also mean that Froome might be disqualified from his Vuelta victory.- Velonews.com

Froome tests for double of allowed limits of Salbutamol during 2017 Vuelta

Kommentaar

Republikein 2025-06-19

Meld asseblief aan om kommentaar te lewer

Froome tests for double of allowed limits of Salbutamol during 2017 Vuelta

Kommentaar

Republikein 2025-06-19

Meld asseblief aan om kommentaar te lewer

MELD AAN

Advertensie